Fate Therapeutics
FATE
$3.80
Share price
-1.81%
Change (1 day)
-37.40%
Change (1 year)
Categories
Fate Therapeutics (FATE) Fails to deliver data
Key failure to deliver metrics for Fate Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.06 M
- Last 3 months FTD volume: $0.2 M
- Last year FTD volume: $1.79 M
Failures to deliver for Fate Therapeutics (FATE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013
Volume in USD (price x number of shares), data since 2013Fate Therapeutics (FATE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.2 M | -90.57% |
| 2023 | $2.15 M | -89.19% |
| 2022 | $19.92 M | -20.28% |
| 2021 | $24.99 M | 31.2% |
| 2020 | $19.05 M | 9.95% |
| 2019 | $17.32 M | 59.52% |
| 2018 | $10.86 M | 1415.4% |
| 2017 | $0.71 M | 181.93% |
| 2016 | $0.25 M | -79.05% |
| 2015 | $1.21 M | -17.49% |
| 2014 | $1.47 M | -81.78% |
| 2013 | $8.07 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Becton Dickinson BDX | $25.98 M | $0.12 B | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $6.44 M | $36.3 M | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.23 M | $11.86 M | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $15.59 M | $35.11 M | 🇺🇸 USA |
 Avidity Biosciences RNA | $4.54 M | $5.58 M | 🇺🇸 USA |